agilon health (NYSE:AGL) Coverage Initiated at Macquarie

Research analysts at Macquarie initiated coverage on shares of agilon health (NYSE:AGL) in a research note issued on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $3.00 price target on the stock. Macquarie’s price objective would suggest a potential upside of 49.63% from the company’s previous close.

AGL has been the topic of several other reports. Stifel Nicolaus dropped their price objective on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Evercore ISI dropped their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. TD Cowen decreased their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Sanford C. Bernstein started coverage on shares of agilon health in a report on Wednesday, December 11th. They set a “market perform” rating and a $2.50 target price for the company. Three investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $4.28.

agilon health Price Performance

Shares of AGL opened at $2.01 on Monday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm’s 50-day simple moving average is $2.40 and its two-hundred day simple moving average is $4.32. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $13.45. The stock has a market cap of $826.10 million, a PE ratio of -2.13 and a beta of 0.51.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period last year, the firm posted ($0.06) earnings per share. Analysts anticipate that agilon health will post -0.52 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Karen Mcloughlin bought 25,000 shares of the company’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Diana Mckenzie bought 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. State Street Corp grew its stake in shares of agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares during the last quarter. Geode Capital Management LLC boosted its holdings in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after acquiring an additional 84,889 shares during the period. Citigroup Inc. grew its position in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC increased its stake in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. Finally, Barclays PLC lifted its position in shares of agilon health by 21.2% during the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after purchasing an additional 214,830 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.